Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Guidelines for Authors
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.0
Impact Factor 2025
1.5
CiteScore 2025
1.0
Impact Factor 2025
1.5
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Saree cancer in Indian woman treated successfully with multimodality management

    Unmesh Vidyadhar Takalkar, Shilpa Balaji Asegaonkar, Pushpa Kodlikeri, Ujwala Kulkarni, Virendrakumar Borundiya, Suresh H. Advani
    22-05-2014
    https://doi.org/10.4081/dr.2014.5128
    2352
    PDF: 786
    HTML: 411
  • 23 | Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: an international retrospective study Maria Chiara Sergi*1, Teresa Amaral*2, Piotr Rutkowski*3, Marie-Lena Rasch2, Naima Benannoune4, Patricio Serra5, Maria Grazia Vitale6, Diana Giannarelli7, Ana Maria Arance8, Eva Munoz Couselo9, Bart Neyns10, Iris Dirven11, Marco Tucci12, Michele Guida13, Francesco Spagnolo14, Ernesto Rossi15, Paola Queirolo16, Pietro Quaglino17, Roberta Depenni18, Joanna Placzke3, Anna Maria Di Giacomo19, Michele Del Vecchio20, Alice Indini20, Ines Pires da Silva21, Alexander M. Menzies22, Angela Hong23, Paul Lorigan5, Caroline Robert24, Georgina V. Long22, Paolo A. Ascierto6, Mario Mandalà25 | 1Unit of Medical Oncology, "Mons. A.R. Dimiccoli" Hospital, Asl BT, Barletta, Italy; 2Skin Cancer Clinical Trials Center, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. 3Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. 4Gustave Roussy Cancer Campus, Villejuif, France. 5The University of Manchester, Manchester, UK. 6Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione "G. Pascale" Napoli, Naples, Italy; 7Epidemiology and Biostatistics, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy; 8Hospital Clínic Barcelona and IDIBAPS, Barcelona, Spain; 9Department of medical oncology. Vall d"Hebron Hospital, Barcelona, Spain & Vall d’Hebron Institute of oncology, VHIO. Barcelona, Spain; 10Department of Medical Oncology, UZ Brussel, Brussels, Belgium. 11Department of medical oncology, Vrije Universiteit Brussel, VUB, Universitair Ziekenhuis Brussel, Brussels, Belgium; 12Medical Oncology Unit, University of Bari Aldo Moro, Policlinico Hospital of Bari, 70124 Bari, Italy. 13Rare Tumors and Melanoma Unit, IRCCS Istituto dei Tumori "Giovanni Paolo II," Bari, Italy. 14IRCCS Ospedale Policlinico San Martino, Skin Cancer Unit, Genova, Italy; 15Medical Oncology, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy; 16IEO European Institute of Oncology, IRCCS, Milan, Italy. 17Department of Dermatology, University of Turin, Turin, Italy. 18University of Modena and Reggio Emilia, Department of Oncology, Hematology, Modena, Emilia-Romagna, Italy; 19Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. 20Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 21Melanoma Institute Australia, University of Sydney, and Blacktown Hospital, Sydney, New South Wales, Australia; 22Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia; 23Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Australia; Department of Radiation Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia; 24Gustave Roussy and Paris-Saclay University, Villejuif, France; 25Unit of Medical Oncology, University of Perugia, Perugia, Italy. § on behalf of the Italian Melanoma Intergroup - IMI.

    Italian Melanoma Intergroup
    11-12-2025
    https://doi.org/10.4081/dr.2025.10765
    417
  • Real-world experience with vismodegib and sonidegib in advanced basal cell carcinoma: a multicenter Italian study

    Mario Valenti, Sara Di Giulio, Andrea Carugno, Pasquale Frascione, Angelo Valerio Marzano, Santo Raffaele Mercuri, Gianluca Nazzaro, Giulia Spallone, Giovanni Paolino, Marco Ardigò
    18-02-2025
    https://doi.org/10.4081/dr.2025.10196
    686
    PDF: 581
    HTML: 28
  • The use of chemotherapeutics for the treatment of keloid scars

    Christopher David Jones, Luke Guiot, Mike Samy, Mark Gorman, Hamid Tehrani
    21-05-2015
    https://doi.org/10.4081/dr.2015.5880
    4009
    PDF: 1876
    HTML: 567
  • 06 | PERIOCULAR “ULCUS RODENS-LIKE” SQUAMOUS CELL CARCINOMA TREATED WITH CEMIPLIMAB: A CASE REPORT A. Zordan1, M. Fino1, N. Di Meo1, I. Zalaudek1, C. Defferrari2, S. Sola3, C. Massone4 | 1Department of Dermatology and Venereology, University of Trieste, Maggiore Hospital, Trieste, Italy; 2Department of Oncology, Galliera Hospital, Genoa, Italy; 3Department of Pathology, Galliera Hospital, Genoa, Italy; 4Department of Dermatology, Galliera Hospital, Genoa, Italy

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11062
    105
    PDF: 37
  • Blue diode laser as supportive therapy for the management of vulvar lichen sclerosus

    Serena Bergamo, Margherita Gobbo, Silvia Chimenton, Giorgia D'Angelo, Luca Guarda Nardini, Alessandro Gatti
    09-08-2024
    https://doi.org/10.4081/dr.2024.10046
    2700
    PDF: 835
    SUPPLEMENTARY MATERIAL: 280
    HTML: 153
  • Survey of the impact of BOLT-trial data on oncologists’ and dermatologists’ decision-making in treating patients with locally advanced basal cell carcinoma

    Luigi Scarpato, Marco Palla, Sabino Strippoli, Luca Tagliaferri, Luca Fania, Maristella Saponara, Anna Carbone, Francesco Spagnolo, Flavia Silvestri, Paolo Antonio Ascierto
    03-07-2024
    https://doi.org/10.4081/dr.2024.9882
    1223
    PDF: 664
    HTML: 138
  • Scleredema diabeticorum

    Mariana Pereira, Rita Ramos Pinheiro, André Lencastre, Elvira Bártolo
    21-11-2022
    https://doi.org/10.4081/dr.2022.9477
    2546
    PDF: 796
    HTML: 176
  • Cutaneous Rosai-Dorfman disease: a case report of disease limited only to skin

    Aurėja Kontrimienė, Emilija Šerpytienė, Monika Macejevska, Jonas Lauraitis, Jūratė Grigaitienė
    29-07-2021
    https://doi.org/10.4081/dr.2021.9261
    3233
    PDF: 797
    HTML: 42
1 - 9 of 9 items

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.